Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee

Western Journal of Medicine

Volumn 172, Issue 2, 2000, Pages 91-94

  Rindone, Joseph P ^a   Hitler, Debra ^a   Collacott, Edward ^a   Nordhaugen, Natalie ^a   Arriola, Greg ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSAMINE;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; DOUBLE-BLIND METHOD; FEMALE; GLUCOSAMINE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; TREATMENT OUTCOME;

EID: 0034132101     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: 10.1136/ewjm.172.2.91     Document Type: Article

References (18)

1. Tapadinhas MJ, Rivera IC, Bignamini AA. Oral glucosamine sulphate in the management of arthrosis: report on a mulit-centre open investigation in Portugal. Pharmatherapeutica 1982;3:157-168.
2. Muller-Fabbender H, Bach GL, Haase W, et al. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 1994;2:61-69.
3. Vaz AL. Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients. Curr Med Res Opin 1982;8:145-149.
4. Noack W, Fisher M, Forster KK, et al. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage 1994;2:51-59.
5. Drovanti A, Bignamini AA, Rovati AL. Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. Clin Ther 1980;3:260-272.
6. Vajaradul Y. Double-blind evaluation of intra-articular glucosamine in outpatients with gonarthrosis. Clin Ther 1980;3:260-272.
7. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. Arthritis Rheum 1995;38:1541-1546.
8. Kellgren JH, Lawrence JS. Radiologic assessment of osteoarthritis. Ann Rheum Dis 1957;16:494-502.
9. Flaherty SA. Pain measurement tools for clinical practice and research. J Am Assoc Nurse Anesth 1996;64:133-139.
10. Flandry F, Hunt JP, Terry GC, et al. Analysis of subjective knee complaints using visual analog scales. Am J Sports Med 1991;19:112-118.
11. Du V Florey C. Sample size for beginners. BMJ 1993;306:1181-1184.
12. Barclay TS, Tsourounis C, McCart GM. Glucosamine. Ann Pharmacother 1998;32:574-579.
13. Ravaud P, Auleley GR, Ayral X et al. Piroxicam therapy: a double blind, randomized multicenter study comparing 2 versus 4 week treatment in patients with painful knee osteoarthritis with effusion. J Rheumatol 1998;25:242-2431.
14. Makarowski W, Weaver A, Rubin B, et al. The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee. Clin Ther 1996;18:114-124.
15. Burkhardt D, Ghosh P. Laboratory evaluation of antiarthritic drugs as potential chondroprotective agents. Semin Arthritis Rheum 1987;17(suppl 1):3S-34S.
16. Uebelhart D, Thonar EJ, Delmas PD, et al. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage 1998;6(suppl A):39-46.
17. Bucsi L, Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 1998;6(suppl A):31-36.
18. Leffler CT, Philippi AF, Leffler SG, et al. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back a randomized, double-blind, placebo-controlled pilot study. Mil Med 1999;164:85-91.